Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 458-680-3 | CAS number: 797751-44-1 WASOX-VMAC2
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- February 6, 2007
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- There are no deviations from the recommended guideline. Meets the requirements of GLP
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 007
- Report date:
- 2007
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- no
- GLP compliance:
- yes
- Type of assay:
- mammalian erythrocyte micronucleus test
Test material
- Reference substance name:
- acetone O,O'-[methoxy(vinyl)silanediyl]oxime; acetone O,O',O''-(vinylsilanetriyl)oxime and acetone O-[dimethoxy(vinyl)silyl]oxime
- IUPAC Name:
- acetone O,O'-[methoxy(vinyl)silanediyl]oxime; acetone O,O',O''-(vinylsilanetriyl)oxime and acetone O-[dimethoxy(vinyl)silyl]oxime
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- other: Crl:NMRI BR
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Deutschland GmbH, D-97633 Sulzfeld
- Age at study initiation: Approx. 9 weeks at time of application
- Weight at study initiation: The body weight of one male of the positive control group was outside the range of ±20 % from the mean at allocation. As this deviation did not concern the test substance groups and was not regarded as possibly influencing the outcome of this study, it was tolerated. No other deviations from the protocol and no unforeseen events occurred.
- Assigned to test groups randomly: yes
- Fasting period before study: feed is withdrawn the evening before the administration and offered again about three hours after the administration.
- Housing: Males: Makrolon cages type II (22 cm x 16.5 cm x 14 cm), single caging. Females: Makrolon cages, type III, low version (39 cm x 23 cm bottom area, 15 cm height), five animals per cage.
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): Tap water, offered in Makrolon bottles with stainless steel canules, ad libitum.
- Acclimation period: 12 days (main study)
ENVIRONMENTAL CONDITIONS
- Temperature (°C): Average of 22 °C, continuous control and recording.
- Humidity (%): Average of 40 %, continuous control and recording.
- Air changes (per hr): 12 per hour.
- Photoperiod (hrs dark / hrs light): Artificial light from 6:00 a.m. to 6:00 p.m.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Justification for choice of solvent/vehicle: The test substance is not soluble in water. Corn oil is a common vehicle for acute oral toxicity testing.
- Amount of vehicle (if gavage or dermal): The dose volume was uniformly 10 mL per kg body mass for all groups - Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Separate preparations were made for each dose group (1000, 1500, and 2000 mg per kg body mass) by blending appropriate amounts of the test substance with corn oil. The positive control substance was dissolved in deionised water.
All formulations were prepared freshly before administration and all administrations were performed within a maximum of one and a half hours after preparation. - Duration of treatment / exposure:
- Negative control and high dose level: 24 h and 48 hours after treatment
Positive control, mid dose level and low dose level: 24 h after treatment - Frequency of treatment:
- The treatment was administered once at single dose
Doses / concentrationsopen allclose all
- Dose / conc.:
- 1 000 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 1 500 mg/kg bw/day (actual dose received)
- Dose / conc.:
- 2 000 mg/kg bw/day (actual dose received)
- No. of animals per sex per dose:
- Low and mid dose level: one group of 5 males and 5 females per doses
High dose level: two groups of 5 males and 5 females; furthermore one group of spare animals was included.
Negative control: two groups of 5 males and 5 females
Positive control: one group of 5 males and 5 females - Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Cyclophosphamide dissolved in deionised water.
- Route of administration: the positive control substance was administered orally per gavage (stomach intubation). The dose volume was 10 mL per kg body mass.
- Doses / concentrations: 40 mg/kg body mass
Examinations
- Tissues and cell types examined:
- Composition of bone marrow and micronucleated erythrocytes
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION: In a range-finding study, doses of 1000, 1500 or 2000 mg "Wasox-VMAC2" per kg body mass, respectively, were administered. No adverse reactions were noted in any animal of any group and all animals survived until 48 hours p.a. No marked cytotoxicity was noted at the evaluation of the bone marrow of the animals of the test substance groups. Therefore 2000 mg per kg body mass was chosen as the high dose for the main study and 1000 mg/kg as the low dose. 1500 mg/kg was arbitrarily chosen as the mid dose.
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
The test substance, the negative control substance and the positive control substance were administered orally per gavage (stomach intubation). The dose volume was uniformly 10 mL per kg body mass for all groups.
Two sampling times was performed at 24 and 48 hours after treatment.
DETAILS OF SLIDE PREPARATION:
Animals were killed by cervical dislocation at the appropriate sampling times, i.e. 24 and 48 hours p.a. Bone marrow was obtained from both femurs and was prepared according to the method of W. SCHMID (The micronucleus test for cytogenetic analysis. In: Hollaender, Chemical Mutagens, Vol.4; Plenum Press New York and London, 1976). For each animal three smears were prepared. Two of them were stained using a slightly modified Pappenheim method, coded and scored. Decoding was done after the scoring of the last slide.
METHOD OF ANALYSIS: A Nikon microscope at a magnification of about 1000 was used for scoring. - Evaluation criteria:
- Criteria for the identification of a micronucleus were: the particle had to be round-shaped, of violet or dark blue colour, inside the cell and looking like a compact body when lifting and lowering the objective. Nearly all of the micronuclei had a diameter not smaller than one tenth of the diameter of the enclosing erythrocyte.
- Statistics:
- Micronucleated cells: U-test of Wilcoxon, Mann and Witney was used for comparison of two groups and H-test of Kruskal and Wallis followed by the test of Nemenyi for comparison of more than two groups.
Body masses, composition of bone marrow: t-test was used for comparison of two groups and analysis of variance followed by the Scheffe test for comparison of more than two groups.
All statistical analyses were performed separately for each sex.
P = 0.05 was chosen in each test (two-tailed tests).
Results and discussion
Test results
- Key result
- Sex:
- male/female
- Genotoxicity:
- negative
- Remarks:
- at the doses of 2000, 1500 and 1000 mg/kg
- Toxicity:
- no effects
- Remarks:
- at the dose of 2000 mg/kg
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF RANGE-FINDING STUDY
- Dose range: 1000, 1500, and 2000 mg/kg body mass
- Solubility: the test substance is not soluble in water. It was blended with corn oil
- Clinical signs of toxicity in test animals: No adverse reactions were noted in any animal of any group and all animals survived until 48 hours p.a. No marked cytotoxicity was noted at the evaluation of the bone marrow of the animals of the test substance groups.
- Rationale for exposure: 2000 mg/kg of body mass should be the limit dose as indicates the guideline.
- Harvest times: 24 and 48 hours
RESULTS OF DEFINITIVE STUDY
- Ratio of PCE/NCE (for Micronucleus assay): There were no statistically significant differences in the amounts of micronucleated normochromatic erythrocytes between the test substance group animals and the negative controls, neither 24 nor 48 hours after administration.
- Statistical evaluation: There were merely statistically significant differences without any biological relevance in the composition of the bone marrow between the sexes in one negative control group and in the positive control group. No marked or statistically significant differences were noted for any parameter analysed between males and females of the dosed groups.
Any other information on results incl. tables
Summarised Results
Presentation of data by means, standard deviations (sd) and number of animals (n). Significant differences to the corresponding negative control groups are indicated by underline nunber
NC % nucleated cells (percentage of all cells)
PE % polychromatic erythrocytes (percentage of all erythrocytes)
NE % normochromatic
erythrocytes (percentages of all erythrocytes)
ratio PE/NE ratio
of polychromatic to normochromatic erythrocytes
MPE%o micronucleated polychromatic erythrocytes (1/1000 polychromatic erythrocytes)
MNE%o micronucleated normochromatic erythrocytes (1/1000 normochromatic erythrocytes)
b.m. body mass
a) statistically significant difference to the other sex of the same group
MALES
group (dose) |
sampling time (h p.a.) |
parameter |
NC % |
PE % |
NE % |
ratio PE/NE |
MPE°/oo |
MNE°/oo |
NC1 negative control |
24 |
mean sd n |
53.9 1.3 5 |
51.2 0.4 5 |
48.8 0.4 5 |
1.05 0.02 5 |
0.00 0.00 5 |
0.00 0.00 5 |
NC2 negative control |
48 |
mean sd n |
56.1 1.6 5 |
a)52.7 0.7 5 |
a)47.3 0.7 5 |
a)1.12 0.03 5 |
0.00 0.00 5 |
0.00 0.00 5 |
A test substance (1000 mg/kg b.m.) |
24 |
mean sd n |
56.0 1.5 5 |
52.9 0.3 5 |
47.1 0.3 5 |
1.12 0.02 5 |
0.00 0.00 5 |
0.00 0.00 5 |
B test substance (1500 mg/kg b.m.) |
24 |
mean sd n |
56.7 0.7 5 |
53.5 0.8 5 |
46.5 0.8 5 |
1.15 0.04 5 |
0.00 0.00 5 |
0.42 0.94 5 |
C1 test substance (2000 mg/kg b.m.) |
24 |
mean sd n |
56.9 2.0 5 |
52.9 2.0 5 |
47.1 2.0 5 |
1.13 0.09 5 |
0.00 0.00 5 |
0.00 0.00 5 |
C2 test substance (2000 mg/kg b.m.) |
48 |
mean sd n |
56.1 2.2 5 |
53.8 0.8 5 |
46.2 0.8 5 |
1.16 0.04 5 |
0.00 0.00 5 |
0.00 0.00 5 |
PC positive control |
24 |
mean sd n |
50.5 0.8 5 |
57.4 0.5 5 |
42.6 0.5 5 |
1.35 0.03 5 |
8.30 0.76 5 |
0.00 0.00 5 |
FEMA
group (dose) |
sampling time (h p.a.) |
parameter |
NC % |
PE % |
NE % |
ratio PE/NE |
MPE°/oo |
MNE°/oo |
NC1 negative control |
24 |
mean sd n |
54.5 0.8 5 |
51.1 0.4 5 |
48.9 0.4 5 |
1.04 0.01 5 |
0.00 0.00 5 |
0.00 0.00 5 |
NC2 negative control |
48 |
mean sd n |
56.0 1.5 5 |
a) 51.4 0.9 5 |
a) 48.6 0.9 5 |
a) 1.06 0.04 5 |
0.00 0.00 5 |
0.00 0.00 5 |
A test substance (1000 mg/kg b.m.) |
24 |
mean sd n |
57.1 1.3 5 |
52.9 0.6 5 |
47.1 0.6 5 |
1.13 0.03 5 |
0.00 0.00 5 |
0.00 0.00 5 |
B test substance (1500 mg/kg b.m.) |
24 |
mean sd n |
55.9 1.3 5 |
53.6 0.2 5 |
46.4 0.2 5 |
1.16 0.01 5 |
0.00 0.00 5 |
0.00 0.00 5 |
C1 test substance (2000 mg/kg b.m.) |
24 |
mean sd n |
55.0 1.9 5 |
53.1 0.8 5 |
46.9 0.8 5 |
1.13 0.04 5 |
0.00 0.00 5 |
0.00 0.00 5 |
C2 test substance (2000 mg/kg b.m.) |
48 |
mean sd n |
55.0 2.6 5 |
53.3 0.8 5 |
46.7 0.8 5 |
1.14 0.04 5 |
0.10 0.22 5 |
0.00 0.00 5 |
PC positive control |
24 |
mean sd n |
54.4 2.1 5 |
57.5 0.8 5 |
42.5 08 5 |
1.35 0.04 5 |
8.20 0.45 5 |
0.00 0.00 5 |
Applicant's summary and conclusion
- Conclusions:
- The test substance did not produce relevant increases of the numbers of micronuclei in polychromatic erythrocytes in animals of either sex of the test species at doses of 1000, 1500 or 2000 mg per kg body mass and sampling times of 24 and 48 hours p.a. No cytotoxicity was noted even at the high dose of 2000 mg per kg body mass which is the highest dose to be tested according to the respective guideline.
- Executive summary:
The Mammalian Erythrocyte Micronucleus Test was performed to detect the possible formation of micronuclei, induced by the test substance, as a result of chromosomal damage or of a damage to the mitotic apparatus of mice.
The study was carried out with Crl:NMRI BR-mice. Dilutions of the test substance in corn oil were administered once at single doses of 1000, 1500 or 2000 mg per kg body mass orally by gavage to 5 male and 5 female mice each. Two negative control groups (corn oil) and one positive control group (cyclophosphamide, dissolved in deionised water) were also included in the study. One group of 5 male and 5 female spare animals, dosed with 2000 mg test substance per kg body mass, served for replacement of possible unscheduled deaths in the high dose group. The dose volume was uniformly 10 mL per kg body mass.
The sampling times were at 24 and at 48 hours after administration.
The test substance did not produce relevant increases of the numbers of micronuclei in polychromatic erythrocytes in animals of either sex of the test species at doses of 1000, 1500 or 2000 mg per kg body mass and sampling times of 24 and 48 hours p.a. No cytotoxicity was noted even at the high dose of 2000 mg per kg body mass which is the highest dose to be tested according to the respective guideline.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
